Retrospective review of cytotoxic chemotherapy and anti-angiogenic combinations in renal cell carcinoma: A single institution experience.

被引：0
|
作者：
Carthon, Bradley Curtis
Tabba, Manal
Ellis, Carla
Harris, Wayne
Bilen, Mehmet Asim
Canter, Daniel
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
523
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-Angiogenic Therapy in Renal Cell Carcinoma
    Sharma, Shree G.
    Nanda, Sudip
    Longo, Santo
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (01) : 77 - 83
  • [2] Titanocenes: Cytotoxic and Anti-angiogenic Chemotherapy Against Advanced Renal-Cell Cancer
    Hogan, Megan
    Tacke, Matthias
    MEDICINAL ORGANOMETALLIC CHEMISTRY, 2010, 32 : 119 - 140
  • [3] Metastatic renal cell carcinoma in the elderly: A single Irish institution experience.
    Sui, Jane Sze Yin
    Rahman, Rozana
    Osman, Noorsyakira
    Harrold, Emily
    Corrigan, Lynda
    Healy, Laura
    Linehan, Anna
    Komanyane, Lore Kabo
    McMahon, Eileen
    Selvadurai, Paul
    Karadawi, Nabeeha
    Duffy, Austin G.
    Higgins, Michaela Jane
    Carney, Desmond N.
    Gallagher, David James
    McCaffrey, John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
    Granet-Vaissiere, Estelle
    Lefort, Felix
    Domblides, Charlotte
    Larroquette, Mathieu
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Gross-Goupil, Marine
    CANCERS, 2023, 15 (04)
  • [5] Prognostic Factors and Overall Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Anti-angiogenic Therapies - Results of a Large Experience From a Single Institution
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Mattana, F.
    Guadalupi, V.
    Gelsomino, F.
    Stagni, S.
    Salvioni, R.
    Buzzoni, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S520 - S520
  • [6] Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma
    Heng, Daniel Y. C.
    Bukowski, Ronald M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (08) : 676 - 682
  • [7] Small cell bladder carcinoma: Single institution experience.
    Wheelden, Megan
    Kaag, Matthew
    Zhu, Junjia
    Holder, Sheldon L.
    Drabick, Joseph J.
    Raman, Jay D.
    Tuanquin, Leonard
    Merrill, Suzanne
    Warrick, Joshua
    Joshi, Monika
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [8] Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
    Ainsworth, Nicola L.
    Lee, Jean S. Z.
    Eisen, Tim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (12) : 1793 - 1805
  • [9] Anti-angiogenic treatment in the management of metastatic renal cell carcinoma
    Sire, Marie
    Wallerand, Herve
    Kilkoski, Florence
    Grenier, Nicolas
    Ferriere, Jean-Marie
    Ravaud, Alain
    BULLETIN DU CANCER, 2008, 95 (09) : 813 - 820
  • [10] Microphysiological model of renal cell carcinoma to inform anti-angiogenic therapy
    Virumbrales-Munoz, Maria
    Ayuso, Jose M.
    Loken, Jack R.
    Denecke, Kathryn M.
    Rehman, Shujah
    Skala, Melissa C.
    Beebe, David J.
    Abel, E. Jason
    BIOMATERIALS, 2022, 283
12345